Tran Nguyen
CIK: 0001457013
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PROTHENA CORP PUBLIC LTD CO
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 28, 2026PRTA
PROTHENA CORP PUBLIC LTD CO
Exercise(M)Direct57K shares- - Jul 28, 2026PRTA
PROTHENA CORP PUBLIC LTD CO
Disposition(D)Direct57K shares at avg. $8.56$488K - Mar 3, 2026PRTA
PROTHENA CORP PUBLIC LTD CO
Award(A)DirectStock Option (Right to Buy)
230K shares- - Jul 28, 2025PRTA
PROTHENA CORP PUBLIC LTD CO
Award(A)Direct95K shares- - Mar 5, 2025PRTA
PROTHENA CORP PUBLIC LTD CO
Award(A)DirectStock Option (Right to Buy)
107.5K shares- - Apr 8, 2020PRTA
PROTHENA CORP PUBLIC LTD CO
Other(J)Direct995 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 28, 2026 | PRTA PROTHENA CORP PUBLIC LTD CO | Exercise(M) | 57,000 | - | $0 | Direct |
| Jul 28, 2026 | PRTA PROTHENA CORP PUBLIC LTD CO | Disposition(D) | 57,000 | $8.56 | $487,920 | Direct |
| Mar 3, 2026 | PRTA PROTHENA CORP PUBLIC LTD CO | Award(A) Stock Option (Right to Buy) | 230,000 | - | - | Direct |
| Jul 28, 2025 | PRTA PROTHENA CORP PUBLIC LTD CO | Award(A) | 95,000 | - | - | Direct |
| Mar 5, 2025 | PRTA PROTHENA CORP PUBLIC LTD CO | Award(A) Stock Option (Right to Buy) | 107,500 | - | - | Direct |
| Apr 8, 2020 | PRTA PROTHENA CORP PUBLIC LTD CO | Other(J) | 995 | - | - | Direct |
1-6 of 6 transactions
About Nguyen Tran
Nguyen Tran (SEC CIK 0001457013) files insider reports with the SEC as Chief Strategy Officer and CFO of PROTHENA CORP PUBLIC LTD CO (PRTA).
Signal8 holds 5 ownership filings by Nguyen Tran, all Form 4s, filed between Feb 14, 2025 and Jul 30, 2026. Those filings report 6 transactions, from Apr 8, 2020 to Jul 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Nguyen Tran's filings is in BRISBANE, CA.
Recent filings by Nguyen Tran
- Jul 28, 2026: Option exercise of PRTA shares (Form 4, code M).
- Jul 28, 2026: Disposition to issuer transaction of PRTA shares (Form 4, code D).
- Mar 3, 2026: Grant or award of PRTA derivative securities (Form 4, code A).
- Jul 28, 2025: Grant or award of PRTA shares (Form 4, code A).
- Mar 5, 2025: Grant or award of PRTA derivative securities (Form 4, code A).
Other insiders filing for PROTHENA CORP PUBLIC LTD CO (PRTA)
- SCULLY WILLIAM P, 10% Owner
- Fennell Todd W., 10% Owner
- Zago Wagner M., Chief Scientific Officer
- Walker Karin L, Chief Accounting Officer
- Swanson Chad J., Chief Development Officer
- Smith Brandon S., Chief Operating Officer